These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7690952)

  • 1. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
    Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
    Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
    Gould VE; Koukoulis GK; Virtanen I
    Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
    Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.
    Shoji T; Kamiya T; Tsubura A; Hatano T; Sakakura T; Yamamoto M; Morii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):53-6. PubMed ID: 1378984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
    Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
    Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
    Jones JL; Critchley DR; Walker RA
    J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
    Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
    J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue.
    Lightner VA; Marks JR; McCachren SS
    Exp Cell Res; 1994 Feb; 210(2):177-84. PubMed ID: 7507849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin expression in normal and abnormal human endometrium.
    Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
    Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
    Ishihara A; Yatani R; Sakakura T
    Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin in reactive lymph nodes and in malignant lymphomas.
    Soini Y; Alavaikko M; Lehto VP; Virtanen I
    Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin patterns of expression in duct carcinoma in situ of the breast.
    Iskaros BE; Sison CP; Hajdu SI
    Ann Clin Lab Sci; 2000 Jul; 30(3):266-71. PubMed ID: 10945566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
    Sunardhi-Widyaputra S; Van Damme B
    Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tenascin-C expression in human breast tumors].
    Tökés AM; Kulka J
    Orv Hetil; 2003 Sep; 144(39):1901-7. PubMed ID: 14598568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
    Yano S
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can tenascin be redundant in cancer development?
    Sakakura T; Kusakabe M
    Perspect Dev Neurobiol; 1994; 2(1):111-16. PubMed ID: 7530137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of tenascin in stomach cancer. An immunohistochemical study].
    Broll R; Kayser K; Vollmer G; Plagemann M; Bruch HP
    Zentralbl Pathol; 1994 Jul; 140(2):123-8. PubMed ID: 7524650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.